Hematological malignancies.
Showing 26 - 50 of 3,813
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)
Not yet recruiting
- Advanced Solid Tumors
- Hematological Malignancies
- (no location specified)
Apr 14, 2022
CART Therapy Trial in Madrid
Completed
- CART Therapy
-
Madrid, SpainAngel Cedillo
May 26, 2022
Hematological Malignancies - SANGUINE
Recruiting
- Hematologic Malignancy
- Blood sampling for HemaChip screening/diagnostic testing
- Bone marrow sampling
-
Olomouc, Czechia
- +3 more
Feb 9, 2023
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Hematological Malignancy, Lymphoma Trial in Canton (SG2501)
Recruiting
- Hematological Malignancy
- Lymphoma
-
Canton, OhioGabrail Cancer Center Research, LLC
Aug 3, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Nutritional Supplement Drink
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Hematological Malignancies Trial in Tianjin (ICP-248)
Not yet recruiting
- Hematological Malignancies
-
Tianjin, Tianjin, ChinaHematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)
Recruiting
- Hematological Malignancies
- Hematopoietic Stem Cell Transplantation
- PBSCs
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022
B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)
Recruiting
- B-Cell Prolymphocytic Leukemia
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 18, 2022
T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- +3 more
- Universal CD7-specific CAR gene-engineered T cells
-
Beijing, Beijing, China
- +2 more
Aug 17, 2023
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
Tissue Microarray of Hematological Malignancies
Active, not recruiting
- Hematological Malignancies
-
Tampere, FinlandTampere Univerisity Hospital
Sep 30, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Beijing (Ex-vivo expanded ?d T cell infusion)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Ex-vivo expanded γδ T cell infusion
-
Beijing, ChinaChinese PLA General Hospital
Mar 24, 2022
AML Trial in Hangzhou (CD38 CAR T-cells)
Recruiting
- AML
- CD38 CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Feb 13, 2022
Hypoxic Red Blood Cells for Burns and Hematological Malignancies
Recruiting
- Hematologic Neoplasms
- Burns
- Hypoxic Red Blood Cells
-
Bergen, NorwayHaukeland University Hospital
Sep 19, 2022
AML Trial in Hangzhou (CLL1 CAR T-cells)
Recruiting
- AML
- CLL1 CAR T-cells
-
Hangzhou, Zhejiang, China
- +1 more
Feb 13, 2022
Invasive Fungal Infections Trial in Italy
Completed
- Invasive Fungal Infections
-
Bologna, Italy
- +13 more
Oct 25, 2022
Detection of Bloodstream Pathogens in Hematological Malignancies
Completed
- Bloodstream Infection
- blood culture
- +3 more
-
Assiut, EgyptAssiut university hospital
Feb 15, 2022